Phase 1
Completed N=62
Safety of BB-12 Supplemented Strawberry Yogurt For Healthy Children
Children
Source: ClinicalTrials.gov NCT01652287 ↗
Enrolled (actual)
62
Serious AEs
5.0%
Results posted
Mar 2017
Primary outcomePrimary: Number of Adverse Events — 61; 35; 52; 38 Number of AE reported
Summary
The investigators believe a readily available drink containing a high dose of probiotics has the potential to improve compliance through many of these mechanisms. This product also has the potential to positively impact the health of children and adults around the world, as yogurt will likely be more appealing to both children and their parents for long term consumption than pharmaceutical-like preparations. In addition to the benefits associated with the consumption of probiotics, there is an increased health benefit from consuming yogurt, a nutrient dense food.
More specifically, the rationale for this Phase I study is to determine safety of this yogurt drink and comply with FDA recommendations pertaining to an Investigational New Drug application. The investigators hypothesize that BB-12 is safe in generally healthy children ages 1-5 years.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Adverse Events |
61; 35; 52; 38 | — |
| SECONDARY Overall Composition of the Gut Microbiota |
71.7; 74.1; 14.7; 11.6; 11.1; 11.9 | — |
Eligibility Criteria
Inclusion criteria for parents/caregivers are:
- Ability to read, speak and write English or Spanish
- Access to a refrigerator for proper storage of drink
- Telephone access
Inclusion criteria for children are:
- Are between the ages of 1 and 5 years
Exclusion Criteria
- Developmental delays
- Any chronic condition, such as diabetes or asthma, that requires medication
- Prematurity, birth weight < 2,500 grams
- Congenital anomalies
- Failure to thrive
- Allergy to strawberry
- Active diarrhea (defined as three or more loose stools for two consecutive days)
- Any other medicines used except anti-pyretic medicines (to reduce fever) [excluding as needed medications]
- Parental belief of lactose intolerance
- History of heart disease, including valvulopathies or cardiac surgery, any implantable device or prosthetic
- History of gastrointestinal surgery or disease
- Milk-protein allergy
- Allergy to any component of the product or the yogurt vehicle
- During the baseline physical exam, have an oxygen saturation rate <96% and respiratory and pulse rate outside the normal range per their age.
Parents/caregivers will also be asked to refrain from giving their child any probiotic foods or supplements during the entire 2 weeks of the active intervention period, and 2 weeks before day 1 of starting the yogurt. Parents will be supplied with a list of products to avoid.
Data sourced from ClinicalTrials.gov (NCT01652287). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.